Global Blood Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Global Blood Therapeutics Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Global Blood Therapeutics Inc Strategy Report

  • Understand Global Blood Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Global Blood Therapeutics Inc: Premium Databases

Global Blood Therapeutics Catalyst Calendar

Proactively evaluate Global Blood Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Global Blood Therapeutics Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 50+ results.
31 Mar 2020 GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Lorem
26 Feb 2020 PDUFA Global Blood Therapeutics Inc - voxelotor Hematological Disorders Sickle Cell Disease Company Press Release
01 Feb 2020 Phase III Trial Initiation Global Blood Therapeutics Inc - voxelotor Hematological Disorders Sickle Cell Disease Clinical Trial Registry
11 Oct 2019 Phase III Trial Results Global Blood Therapeutics Inc - voxelotor Hematological Disorders Sickle Cell Disease Company Press Release
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Gain a 360-degree view of Global Blood Therapeutics Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code